Former Frier Levitt Chair, United Health and McKesson Chief, and federal and state prosecutors establish Health Law Alliance, a specialized healthcare boutique for government investigations, PBM audits, payor disputes, licensing board matters, and regulatory advice.
The firm’s founding partner, Anthony Mahajan, has decades of legal experience in healthcare, having been employed by a National Law Journal Top 20-ranked international law firm, the Department of Justice (DOJ) as an Assistant United States Attorney, McKesson Corp. as Chief Counsel and Vice President, United Health Group as Chief Compliance Officer, and most recently as Chair of Frier Levitt’s White Collar & Government Investigations practice.
In addition, the firm employs the former General Counsel of a publicly traded company, and former New York law firm corporate attorney to assist clients with corporate transactions and restructurings, a state prosecutor with extensive courtroom experience and jury trials, and Super Lawyer “Rising Stars” with experience defending entities throughout the healthcare delivery chain, including health systems, laboratories, pharmacies, physicians, MSOs, and individuals and investors, in criminal and civil matters and administrative proceedings.
As quoted in Law360, peers acknowledge our “more than two decades of crisis-management and extensive federal trial experience,” which provides clients with “strategic perspective and pragmatic solutions” as they “identify and manage risk, remediate significant instances of noncompliance, and respond to regulatory scrutiny.” In short, the firm’s mission is simple: use unmatched experience and insight to defend our clients against insurance conglomerates, the federal government, and state agencies. We used to work for them. Now let us fight for you. Contact us today for a consultation.
MORE ARTICLES BY CATEGORY
Ketamine Clinics & Compounders Now the Focus of Increased DEA Enforcement
The DEA is increasingly targeting ketamine providers with record-keeping inspections and audits, making expert Medicare and DEA compliance defense essential to avoid steep fines and license risks.
Read More >>HLA's Diana Yastrovskaya Featured on Live TV for PBM Expertise
The feature underscores HLA’s mission to elevate thought leadership within the healthcare space and provide trusted expertise on issues that directly impact patients, providers, and policymakers.
Read More >>By Appointment Only: How DME Suppliers Can Prevent Unexpected DME License Revocations
DME suppliers can prevent unexpected and costly license revocations by strategically applying with a "By Appointment Only" designation. This article explores the common compliance trap of failing unannounced site visits due to conflicts between standard pharmacy operating hours and Medicare's "posted hours" requirement for DME suppliers. "By Appointment Only" status is a crucial safeguard, which suppliers can take to implement to protect their DME billing privileges.
Read More >>Resolving Prescription “Red Flags” Is No Longer Optional: Federal Scrutiny Tightens on Controlled-Substance Dispensing
Pharmacists must resolve “red flags” under the Controlled Substances Act’s corresponding-responsibility requirements before dispensing controlled substances. Overlooking warning signs, such as cash-paid, high-dose opioid prescriptions—can now trigger False Claims Act liability and massive penalties, as demonstrated by Walgreens’ $350 million settlement in April 2025.
Read More >>